Normal view
-
cs.AI, q-bio.NC updates on arXiv.org
-
Responsible AI for General-Purpose Systems: Overview, Challenges, and A Path Forward
arXiv:2601.13122v1 Announce Type: new Abstract: Modern general-purpose AI systems made using large language and vision models, are capable of performing a range of tasks like writing text articles, generating and debugging codes, querying databases, and translating from one language to another, which has made them quite popular across industries. However, there are risks like hallucinations, toxicity, and stereotypes in their output that make them untrustworthy. We review various risks and vuln
-
cs.AI, q-bio.NC updates on arXiv.org
-
Virtual Urbanism: An AI-Driven Framework for Quantifying Urban Identity. A Tokyo-Based Pilot Study Using Diffusion-Generated Synthetic Environments
arXiv:2601.13846v1 Announce Type: new Abstract: This paper introduces Virtual Urbanism (VU), a multimodal AI-driven analytical framework for quantifying urban identity through the medium of synthetic urban replicas. The framework aims to advance computationally tractable urban identity metrics. To demonstrate feasibility, the pilot study Virtual Urbanism and Tokyo Microcosms is presented. A pipeline integrating Stable Diffusion and LoRA models was used to produce synthetic replicas of nine Toky
Virtual Urbanism: An AI-Driven Framework for Quantifying Urban Identity. A Tokyo-Based Pilot Study Using Diffusion-Generated Synthetic Environments
-
cs.AI, q-bio.NC updates on arXiv.org
-
Medication counseling with large language models: balancing flexibility and rigidity
arXiv:2601.11544v1 Announce Type: cross Abstract: The introduction of large language models (LLMs) has greatly enhanced the capabilities of software agents. Instead of relying on rule-based interactions, agents can now interact in flexible ways akin to humans. However, this flexibility quickly becomes a problem in fields where errors can be disastrous, such as in a pharmacy context, but the opposite also holds true; a system that is too inflexible will also lead to errors, as it can become too
Medication counseling with large language models: balancing flexibility and rigidity
-
cs.AI, q-bio.NC updates on arXiv.org
-
Measuring Stability Beyond Accuracy in Small Open-Source Medical Large Language Models for Pediatric Endocrinology
arXiv:2601.11567v1 Announce Type: cross Abstract: Small open-source medical large language models (LLMs) offer promising opportunities for low-resource deployment and broader accessibility. However, their evaluation is often limited to accuracy on medical multiple choice question (MCQ) benchmarks, and lacks evaluation of consistency, robustness, or reasoning behavior. We use MCQ coupled to human evaluation and clinical review to assess six small open-source medical LLMs (HuatuoGPT-o1 (Chen 2024
Measuring Stability Beyond Accuracy in Small Open-Source Medical Large Language Models for Pediatric Endocrinology
-
cs.AI, q-bio.NC updates on arXiv.org
-
Knowing When to Abstain: Medical LLMs Under Clinical Uncertainty
arXiv:2601.12471v1 Announce Type: cross Abstract: Current evaluation of large language models (LLMs) overwhelmingly prioritizes accuracy; however, in real-world and safety-critical applications, the ability to abstain when uncertain is equally vital for trustworthy deployment. We introduce MedAbstain, a unified benchmark and evaluation protocol for abstention in medical multiple-choice question answering (MCQA) -- a discrete-choice setting that generalizes to agentic action selection -- integra
Knowing When to Abstain: Medical LLMs Under Clinical Uncertainty
-
cs.AI, q-bio.NC updates on arXiv.org
-
A Cloud-based Multi-Agentic Workflow for Science
arXiv:2601.12607v1 Announce Type: cross Abstract: As Large Language Models (LLMs) become ubiquitous across various scientific domains, their lack of ability to perform complex tasks like running simulations or to make complex decisions limits their utility. LLM-based agents bridge this gap due to their ability to call external resources and tools and thus are now rapidly gaining popularity. However, coming up with a workflow that can balance the models, cloud providers, and external resources i
A Cloud-based Multi-Agentic Workflow for Science
-
cs.AI, q-bio.NC updates on arXiv.org
-
AI-generated data contamination erodes pathological variability and diagnostic reliability
arXiv:2601.12946v1 Announce Type: cross Abstract: Generative artificial intelligence (AI) is rapidly populating medical records with synthetic content, creating a feedback loop where future models are increasingly at risk of training on uncurated AI-generated data. However, the clinical consequences of this AI-generated data contamination remain unexplored. Here, we show that in the absence of mandatory human verification, this self-referential cycle drives a rapid erosion of pathological varia
AI-generated data contamination erodes pathological variability and diagnostic reliability
-
cs.AI, q-bio.NC updates on arXiv.org
-
Neural Organ Transplantation (NOT): Checkpoint-Based Modular Adaptation for Transformer Models
arXiv:2601.13580v1 Announce Type: cross Abstract: We introduce Neural Organ Transplantation (NOT), a modular adaptation framework that enables trained transformer layers to function as reusable transferable checkpoints for domain adaptation. Unlike conventional fine-tuning approaches that tightly couple trained parameters to specific model instances and training data, NOT extracts contiguous layer subsets ("donor organs") from pre-trained models, trains them independently on domain-specific dat
Neural Organ Transplantation (NOT): Checkpoint-Based Modular Adaptation for Transformer Models
-
cs.AI, q-bio.NC updates on arXiv.org
-
Who Should Have Surgery? A Comparative Study of GenAI vs Supervised ML for CRS Surgical Outcome Prediction
arXiv:2601.13710v1 Announce Type: cross Abstract: Artificial intelligence has reshaped medical imaging, yet the use of AI on clinical data for prospective decision support remains limited. We study pre-operative prediction of clinically meaningful improvement in chronic rhinosinusitis (CRS), defining success as a more than 8.9-point reduction in SNOT-22 at 6 months (MCID). In a prospectively collected cohort where all patients underwent surgery, we ask whether models using only pre-operative cl
Who Should Have Surgery? A Comparative Study of GenAI vs Supervised ML for CRS Surgical Outcome Prediction
-
cs.AI, q-bio.NC updates on arXiv.org
-
AI-in-the-Loop: Privacy Preserving Real-Time Scam Detection and Conversational Scambaiting by Leveraging LLMs and Federated Learning
arXiv:2509.05362v4 Announce Type: replace-cross Abstract: Scams exploiting real-time social engineering -- such as phishing, impersonation, and phone fraud -- remain a persistent and evolving threat across digital platforms. Existing defenses are largely reactive, offering limited protection during active interactions. We propose a privacy-preserving, AI-in-the-loop framework that proactively detects and disrupts scam conversations in real time. The system combines instruction-tuned artificial
AI-in-the-Loop: Privacy Preserving Real-Time Scam Detection and Conversational Scambaiting by Leveraging LLMs and Federated Learning
-
cs.AI, q-bio.NC updates on arXiv.org
-
Conformal Prediction-Driven Adaptive Sampling for Digital Water Twins
arXiv:2511.05610v2 Announce Type: replace-cross Abstract: Digital Twins (DTs) for Water Distribution Networks (WDNs) require accurate state estimation with limited sensors. Uniform sampling often wastes resources across nodes with different uncertainty. We propose an adaptive framework combining LSTM forecasting and Conformal Prediction (CP) to estimate node-wise uncertainty and focus sensing on the most uncertain points. Marginal CP is used for its low computational cost, suitable for real-tim
Conformal Prediction-Driven Adaptive Sampling for Digital Water Twins
-
cs.AI, q-bio.NC updates on arXiv.org
-
OpenNovelty: An LLM-powered Agentic System for Verifiable Scholarly Novelty Assessment
arXiv:2601.01576v2 Announce Type: replace-cross Abstract: Evaluating novelty is critical yet challenging in peer review, as reviewers must assess submissions against a vast, rapidly evolving literature. This report presents OpenNovelty, an LLM-powered agentic system for transparent, evidence-based novelty analysis. The system operates through four phases: (1) extracting the core task and contribution claims to generate retrieval queries; (2) retrieving relevant prior work based on extracted que
OpenNovelty: An LLM-powered Agentic System for Verifiable Scholarly Novelty Assessment
-
cs.AI, q-bio.NC updates on arXiv.org
-
LLM-Based Agentic Systems for Software Engineering: Challenges and Opportunities
arXiv:2601.09822v2 Announce Type: replace-cross Abstract: Despite recent advancements in Large Language Models (LLMs), complex Software Engineering (SE) tasks require more collaborative and specialized approaches. This concept paper systematically reviews the emerging paradigm of LLM-based multi-agent systems, examining their applications across the Software Development Life Cycle (SDLC), from requirements engineering and code generation to static code checking, testing, and debugging. We delve
LLM-Based Agentic Systems for Software Engineering: Challenges and Opportunities
-
STAT

-
You don’t have to read Trump’s health care plan, and Tara’s JPM26 takeaways
This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here. Hello! The newsletter didn’t come out yesterday in honor of MLK Day, but we’re back right after Indiana University became national champions. I also want to know why the maple leaf emoji is used so frequently in patients’ medical charts. Palm over face emoji. Runner emoji, mail emoji: bob.herman@statnews.com.Read the rest…
You don’t have to read Trump’s health care plan, and Tara’s JPM26 takeaways
This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.
Hello! The newsletter didn’t come out yesterday in honor of MLK Day, but we’re back right after Indiana University became national champions. I also want to know why the maple leaf emoji is used so frequently in patients’ medical charts. Palm over face emoji. Runner emoji, mail emoji: bob.herman@statnews.com.


© Alex Brandon/AP
-
STAT

-
STAT+: Pharmalittle: We’re reading about drug prices in Europe, a cancer vaccine, and much more
Good morning, everyone, and welcome to another working week, at least for those on our side of the pond, where we are returning from an extended holiday break. As usual this means that the predictable routine of online meetings and deadlines has returned. To cope, we are reaching for the tea kettle to have another cuppa. Our choice today is a blend of matcha, gingko, and a few berries. Please feel free to join us. Meanwhile, we have assembled a lengthy menu of items — a baker’s dozen, in fact —
STAT+: Pharmalittle: We’re reading about drug prices in Europe, a cancer vaccine, and much more
Good morning, everyone, and welcome to another working week, at least for those on our side of the pond, where we are returning from an extended holiday break. As usual this means that the predictable routine of online meetings and deadlines has returned. To cope, we are reaching for the tea kettle to have another cuppa. Our choice today is a blend of matcha, gingko, and a few berries. Please feel free to join us. Meanwhile, we have assembled a lengthy menu of items — a baker’s dozen, in fact — in hopes of easing your own journey today. Best of luck, and we hope you conquer the world. …
U.S. pharmaceutical companies are stepping up their campaign for higher drug prices in Europe, in some cases threatening to withhold new medicines if European lawmakers refuse, The Financial Times says. Pfizer chief executive Albert Bourla, the first pharmaceutical boss to announce a pricing agreement with President Trump last year, said the deal forced Pfizer to increase prices abroad. “When [we] do the math, shall we reduce the U.S. price to France’s level or stop supplying France? We [will] stop supplying France,” Bourla told reporters at the annual J.P. Morgan Healthcare Conference last week. “So they will stay without new medicines. The system will force us not to be able to accept the lower prices.” Other pharmaceutical executives said at the conference that they were quietly considering withholding or delaying drug launches in Europe.
Chinese drugmakers signed a record $135.7 billion in cross-border out-licensing deals in 2025, as global pharmaceutical giants raced to tap China’s growing drug pipeline, Nikkei Asia reports. The sector completed 157 such deals throughout the year, a sharp rise from the $51.9 billion across 94 deals recorded in 2024, according to Chinese data provider PharmCube’s NextPharma database. Pharmaceutical out-licensing typically grants overseas partners some or all of the rights to develop, manufacture, and commercialize a treatment originally developed by the licenser. The surge underscores China’s evolving role as a critical supply center for the global pharmaceutical industry, where multinational corporations are increasingly hunting for assets in fast-growing fields like antibody-drug conjugates and immunotherapy to offset looming patent cliffs, even as domestic firms grapple with the sustainability of these partnerships.
Continue to STAT+ to read the full story…


© Alex Hogan/STAT
-
npj Digital Medicine
-
An artificial intelligence-powered learning health system to improve sepsis detection and quality of care: a before-and-after study
npj Digital Medicine, Published online: 20 January 2026; doi:10.1038/s41746-025-02180-2An artificial intelligence-powered learning health system to improve sepsis detection and quality of care: a before-and-after study
An artificial intelligence-powered learning health system to improve sepsis detection and quality of care: a before-and-after study
npj Digital Medicine, Published online: 20 January 2026; doi:10.1038/s41746-025-02180-2
An artificial intelligence-powered learning health system to improve sepsis detection and quality of care: a before-and-after study-
npj Digital Medicine
-
Clinically-guided models or foundation models? predicting cervical spondylotic myelopathy from electronic health records
npj Digital Medicine, Published online: 20 January 2026; doi:10.1038/s41746-026-02337-7Clinically-guided models or foundation models? predicting cervical spondylotic myelopathy from electronic health records
Clinically-guided models or foundation models? predicting cervical spondylotic myelopathy from electronic health records
npj Digital Medicine, Published online: 20 January 2026; doi:10.1038/s41746-026-02337-7
Clinically-guided models or foundation models? predicting cervical spondylotic myelopathy from electronic health records-
cs.AI, q-bio.NC updates on arXiv.org
-
Japanese AI Agent System on Human Papillomavirus Vaccination: System Design
arXiv:2601.10718v1 Announce Type: new Abstract: Human papillomavirus (HPV) vaccine hesitancy poses significant public health challenges, particularly in Japan where proactive vaccination recommendations were suspended from 2013 to 2021. The resulting information gap is exacerbated by misinformation on social media, and traditional ways cannot simultaneously address individual queries while monitoring population-level discourse. This study aimed to develop a dual-purpose AI agent system that pro
Japanese AI Agent System on Human Papillomavirus Vaccination: System Design
-
cs.AI, q-bio.NC updates on arXiv.org
-
MetaboNet: The Largest Publicly Available Consolidated Dataset for Type 1 Diabetes Management
arXiv:2601.11505v1 Announce Type: cross Abstract: Progress in Type 1 Diabetes (T1D) algorithm development is limited by the fragmentation and lack of standardization across existing T1D management datasets. Current datasets differ substantially in structure and are time-consuming to access and process, which impedes data integration and reduces the comparability and generalizability of algorithmic developments. This work aims to establish a unified and accessible data resource for T1D algorithm
MetaboNet: The Largest Publicly Available Consolidated Dataset for Type 1 Diabetes Management
-
(Multiomics OR Omics) AND (Lung OR gastric OR Hepatocellular)
-
Cellular neighborhoods in cancer
Nat Cancer. 2026 Jan 16. doi: 10.1038/s43018-025-01107-w. Online ahead of print.ABSTRACTThe concept of cellular neighborhoods, defined as recurring structures within the tissue with characteristic cell compositions and interactions, has transformed our understanding of the complexity and dynamics of tumor ecosystems. Recent advances in spatial omics and computational modeling have enabled high-resolution mapping of these neighborhoods, providing unprecedented insights into their roles in shaping
Cellular neighborhoods in cancer
Nat Cancer. 2026 Jan 16. doi: 10.1038/s43018-025-01107-w. Online ahead of print.
ABSTRACT
The concept of cellular neighborhoods, defined as recurring structures within the tissue with characteristic cell compositions and interactions, has transformed our understanding of the complexity and dynamics of tumor ecosystems. Recent advances in spatial omics and computational modeling have enabled high-resolution mapping of these neighborhoods, providing unprecedented insights into their roles in shaping tumor heterogeneity, evolution and therapeutic responses. Despite these advances, a unified framework for interpreting cellular neighborhoods remains lacking. This Perspective synthesizes emerging concepts and insights, focusing on the definition and classification of cellular neighborhoods in cancer, computational methods for identifying and comparing them, and their clinical relevance.
PMID:41545713 | DOI:10.1038/s43018-025-01107-w